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Abstract
Background: Hypersensitivity pneumonitis (HP) is an interstitial lung disease caused by repeated
inhalations of finely dispersed organic particles or low molecular weight chemicals. The disease is
characterized by an alveolitis sustained by CD8(+) cytotoxic T lymphocytes, granuloma formation,
and, whenever antigenic exposition continues, fibrosis. Although it is known that T-cell migration
into the lungs is crucial in HP reaction, mechanisms implicated in this process remain undefined.
Methods:  Using flow cytometry, immunohistochemistry, confocal microscopy analysis and
chemotaxis assays we evaluated whether CXCL10 and its receptor CXCR3 regulate the trafficking
of CD8(+) T cells in HP lung.
Results: Our data demonstrated that lymphocytes infiltrating lung biopsies are CD8 T cells which
strongly stain for CXCR3. However, T cells accumulating in the BAL of HP were CXCR3(+)/
IFNγ (+) Tc1 cells exhibiting a strong in vitro migratory capability in response to CXCL10. Alveolar
macrophages expressed and secreted, in response to IFN-γ , definite levels of CXCL10 capable of
inducing chemotaxis of the CXCR3(+) T-cell line. Interestingly, striking levels of CXCR3 ligands
could be demonstrated in the fluid component of the BAL in individuals with HP.
Conclusion: These data indicate that IFN-γ  mediates the recruitment of lymphocytes into the lung
via production of the chemokine CXCL10, resulting in Tc1-cell alveolitis and granuloma formation.
Background
Hypersensitivity pneumonitis (HP) is an interstitial lung
disease (ILD) caused by the inhalation of and sensitiza-
tion to a variety of environmental organic antigens. The
immune mediated nature of the disorder is testified to by
the characteristic sequel of events taking place in the lung
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after antigenic inhalation: an acute pulmonary neu-
trophilia occurs early followed by an interstitial T-cell
infiltration of CD8 T-cell showing a limited expression of
the T-cell receptor [1].
A number of data point to chemokines as orchestrators of
inflammatory disorders which are characterized by a mas-
sive accumulation of immunocompetent cells within
affected organs, including the lung [2]. Chemokines,
which can be divided into four groups based on the posi-
tioning of the cysteine residues in the mature protein [3-
6], induce directional migration of immune cells through
their interactions with G-protein coupled receptors. Three
chemokines induced by IFN-γ , IFN-γ -inducible protein-10
(IP-10, CXCL10), monokine induced by IFN-  (Mig/
CXCL10), interferon-inducible T-cell α -chemoattractant
(I-TAC/CXCL11) bind to the CXCR3 receptor molecule
which is expressed by activated T lymphocytes and natural
killer cells [7,8]. We have recently found that CXCR3 is
expressed in vivo by CD4+ Th1 infiltrating the lung of
patients with sarcoidosis and by T cells accumulating in
the pulmonary parenchyma of lung-transplant recipients
with rejection episodes [9,10], providing evidence that
CXCR3 expression constitutes an important mechanism
in the regulation of T-cell migration to the lung. Further-
more, recent data in the animal model suggest that
CXCR3/CXCL9, CXCL10, CXCL11 interactions are central
in the pathogenesis of hypersensitivity reactions to Sac-
charopolyspora rectivirgula (SR) and successive granuloma
formation [11].
Using immunohistochemical studies of tissue sections
and a flow cytometry evaluation of cells recovered from
the bronchoalveolar lavage (BAL), we studied the role of
CXCR3/CXCL10 interactions in the regulation of T-cell
migration into the lung of patients with hypersensitivity
pneumonitis. We have shown that CXCR3 is expressed by
T cells accumulating in the lower respiratory tract of
patients with this hypersensitivity disorder. In addition,
we found that signalling of CXCR3 with CXCL10 induces
the  in vitro migration of CXCR3(+)T cells. The ligand
CXCL10 can be detected in pulmonary macrophages and
is released by these cells.
Materials and Methods
Study population
12 HP patients were included in the study (9 males and 3
females; mean age 38.3 ± 6.4 yr). The majority of the
patients had farmer's lung disease (10 patients); 1 patient
had bird fancier's lung, 1 patient had mushroom worker's
lung. The following criteria for HP diagnosis were used: a)
history of exposure to HP antigens, b) a symptomatic
acute episode with chills, fever, cough, breathlessness 4 to
8 hours after exposure to specific antigens, c) radiological
features (mainly diffuse reticular pattern) and/or a func-
tional pattern of interstitial lung disease, and d) evidence
of antibodies against S. rectivirgula in all except one case
(bird fancier's lung). Each patient underwent bronchos-
copy for transbronchial biopsy (TBB) and BAL analysis.
BAL was performed according to the technical recommen-
dations and guidelines for the standardization of BAL pro-
cedures [12]. Briefly, a total of 200 ml of saline solution
was injected in 25-ml aliquots via fiberoptic bronchos-
copy, with immediate vacuum aspiration after each aliq-
uot. Immediately after the BAL, the fluid was filtered
through gauze and the volume measured. A volume of
100-200 ml of BAL recovery and a sample of 50% of the
instilled volume with a minimum of 50 ml was consid-
ered acceptable. The percentage of BAL recovery was
54.9% ± 4.2. Cells recovered from the BAL were washed 3
times with PBS, resuspended in endotoxin tested RPMI
1640 (Sigma Chemical Co., St. Louis, MO) supplemented
with 20 mM HEPES and L-glutamine, 100 U/ml penicil-
lin, 100 µg/ml streptomycin, and 10% FCS (ICN Flow,
Costa Mesa, CA) and then counted. A standard morpho-
logical and immunologic analysis of BAL cellular compo-
nents was performed and included cell recovery,
differential count of macrophages, lymphocytes, neu-
trophils, and eosinophils, and flow cytometry analysis of
the CD4/CD8 BAL T-cell ratio.
Five healthy controls were selected (3 men and 2 women;
average age 37.3 ± 4.3 yr; 2 non-smoking healthy adults
and 3 non-smoking subjects evaluated for complaints of
cough without lung disease). They showed normal physi-
cal examinations, chest X-rays, lung function tests and
BAL cell numbers.
Purification of alveolar macrophages and T cells
Alveolar macrophages (AMs) and T cells were enriched
from the BAL cell suspensions by rosetting with neurami-
nidase-treated SRBC followed by F/H gradient separations
and residual CD3+ lymphocytes were removed using high-
gradient magnetic separation columns (Mini MACS,
Miltenyi Biotec, Germany) [13]. Following this multistep
selection procedure more than 95% of the above cells
were viable, as judged by the trypan blue exclusion test.
Staining with mAb showed that more than 99% of puri-
fied lymphocytes were CD3+ T cells.
Monoclonal antibodies and cytokines
The commercially available conjugated or unconjugated
mAbs used belonged to the Becton Dickinson and
PharMingen series and included: CD3, CD4, CD8, isotype
matched controls. Anti-IL-4 and anti-IFNγ  mAbs were pur-
chased from PharMingen (San Diego, CA). Purified rabbit
anti-human CXCL10 polyclonal antibody (R&D Systems
Inc, Minneapolis, MN) and anti-hCXCR3 mAb (R&D Sys-
tems Inc) were also used.

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Immunohistochemical analysis of CXCR3+ cells and 
CXCL10 producing cells
Open lung biopsies from 8 patients with clinical and his-
tological diagnosis of hypersensitivity pneumonitis were
studied by immunohistochemistry for the immunophe-
notype characterization of inflammatory cells and for
CXCR3 and CXCL10 expression.
Immunohistochemistry for the characterization of
inflammatory infiltrate was carried out using the follow-
ing antibodies (Dako Glostrup, Denmark): CD45 (1:20),
CD43 (1:40), CD45RO (1:100), CD20 (1:100), CD3
(1:50), CD68 (1:50), CD4 (1:100), and CD8 (1:100). The
immunoreaction products were developed using the avi-
din-biotin-peroxidase complex method. Immunostaining
for CXCR3 was performed as previously described. Briefly,
after the microwave antigen retrieval procedure and neu-
tralization of endogenous peroxidase activity, the slides
were incubated with primary antibody for 1 hr in a
humidified chamber at 37°C (anti-hCXCR3 mAb 1:100).
Immunoreactivity was detected using biotinylated sec-
ondary antibodies incubated for 45 min followed by a 30
min incubation with avidin-peroxidase and visualized by
a 7 min incubation with the use of 0.1% 3,3'-diaminoben-
zidene tetrahydrochloride as the chromogen. Parallel con-
trol slides were prepared either lacking primary antibody
or lacking primary and secondary antibodies, or stained
with normal sera to control for background reactivity. The
intensity of antibody staining was classified in three
groups: strong, weak, negative.
Confocal microscopy for the identification of CXCR3+ 
cells
Paraffin sections were prepared for immunofluorescent
labelling. Briefly, primary antibodies against CD3 and
CXCR3 (1:100 diluted and 1:100 diluted in phosphate-
buffered saline with 5 g/L bovine serum albumin and 1 g/
L gelatine, respectively) and secondary antibodies (goat
anti-mouse IgG and donkey anti-goat IgG) conjugated
with TEXAS red or ALEXA 488 (Sigma) were used. Double
labelling using both antibodies on the same section was
performed. Primary antibodies and secondary antibodies
were incubated for 1 h at room temperature. Nuclear
staining was carried out with DAPI (Sigma) in PBS. Slides
were stored at 4°C and analysed within 24 h. As a control,
the primary antibody was omitted.
Immunofluorescence was evaluated with a confocal
microscopy (Biorad 2100 Multiphoton; Hercules, CA),
We used an argon laser at 488 nm in combination with a
helium neon laser at 543 nm to excite the green (CD3)
and red (CXCR3) fluorochromes simultaneously. Emitted
fluorescence was detected with a 505–530 nm band pass
filter for the green signal and a 560 nm long pass filter for
the red signal. Images were analyzed using the Adobe
Photoshop 7.0 program.
Phenotypic evaluation of BAL cells
The frequency of BAL cells positive for the above reagents
was determined by overlaying the flow cytometry histo-
grams of the samples stained with the different reagents as
previously reported [12]. Cells were scored using a FACS-
can® analyzer (Becton Dickinson), and data were proc-
essed using the Macintosh CELLQuest software program
(Becton Dickinson). The expression of cytoplasmic
cytokine was evaluated following permeabilization of cell
membranes using 1:2 diluted PermeaFix (Ortho, Raritan,
NJ) for 40 min. After permeabilization procedures anti-IL-
4, anti-IFN-γ  and anti-CXCL10 antibodies were added.
Since pulmonary cells bear cytoplasmic cytokines in a uni-
modal expression pattern, indicating that the entire cell
population exhibits relatively homogeneous fluorescence,
the percentage of positive cells does not represent the
most accurate way of enumerating positive cells. Mean
fluorescence intensity (MFI) was used to compare the pos-
itivity of these specific antigens on different cell popula-
tions. To evaluate whether the shift of the positive cell
peak was statistically significant, the Kolmogorov-Smir-
nov test for analysis of histograms was used according to
the Macintosh CELLQuest software user's guide (Becton
Dickinson).
For immunofluorescence analysis, control IgG1 and
IgG2a and IgG2b were obtained from Becton-Dickinson;
control rat antiserum consisted of ascites containing an
irrelevant rat IgG2b; control rabbit antiserum consisted of
rabbit IgG (purified protein) purchased from Serotec
(Serotec, U.K.); goat-anti-rabbit IgG and goat F(ab')2 anti-
rat IgG were obtained from Immunotech (Marseille,
France).
Determination of IP-10/CXCL10 and Mig/CXCL9 mRNA 
levels
Each PCR product was analysed and quantitated by Bio-
Rad's Image Analysis System Gel Doc using Quantity One
software (Bio-Rad, Hercules, CA). Briefly, the images of
the gels were acquired from the Gel Doc system densito-
meter and saved in digitised forms to perform volume
analysis. The intensity of each band was differentiated by
the intensity of the background, whose value was sub-
tracted from each individual band and the resulting PCR
product value was expressed in mm*mm*intensity of the
pixels of the specific band in the gel.
Generation of macrophage supernatants
To verify the ability of AMs to release CXCL10, AMs (1 ×
106/ml) were isolated from the BAL of HP patients, resus-
pended in RPMI medium and cultured for 24 hr in 24-
well plates at 37°C in 5% CO2. In separate experimentsRespiratory Research 2005, 6:20 http://respiratory-research.com/content/6/1/20
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AMs were stimulated with IFN-γ  (100 U/ml), PMA (10 ng/
ml) and LPS (10 µg/ml; Difco Lab., Detroit, MI). Follow-
ing the incubation period, supernatants were harvested,
filtered through a 0.45 µm Millipore filter and immedi-
ately stored at -80°C. At the end of the culture time AM
viability was always greater than 95%. Chemotactic activ-
ity of supernatants was determined as reported below.
Migration activity of pulmonary T cells in response to 
CXCLIO
T-cell migration was measured in a 48-well modified
Boyden chamber (AC48 Neuro Probe Inc., USA). The
chamber is made of two sections: different chemotactic
stimuli were loaded in the bottom section while cells were
added in the top compartment. Polyvinylpyrrolidone-free
polycarbonate membranes with 3 to 5 µm pores (for lung
T cells obtained from HP patients and the CXCR3+ and
CXCR3- T-cell lines, respectively) (Osmonics, Livermore,
CA) and coated with fibronectin were placed between the
two chamber parts. Only the bottom face of filters was
pretreated with fibronectin; the fibronectin pretreatment
maximizes attachment of migrating cells to filters, avoid-
ing the possibility that they may not adhere. Using this
procedure in preliminary experiments we demonstrated
that only a trivial number of cells may be recovered in the
bottoms of the wells. To avoid the shedding of fibronec-
tin, fibronectin-treated filters were extensively washed. In
preliminary experiments, fibronectin-treated filters did
not induce spontaneous chemotaxis in absence of
chemokines.
To evaluate the migratory properties of pulmonary T lym-
phocytes rhIP-10/CXCL10 (200 ng/ml) were used. The
CXCR3- and CXCR3+ cell lines (300-19, kindly provided
by Dr. B. Moser, Theodor-Kocher Institute, University of
Bern, Switzerland) were used as negative and positive con-
trols. 30 µl of chemokines or control medium were added
to the bottom wells, and 50 µl of 5.0 × 106 cells/ml T cells
or CXCR3-/+ cells resuspended in RPMI 1640 were added
to the top wells. The chamber was incubated at 37°C with
5% CO2 for 2 hrs. The membranes were then removed,
washed with PBS on the upper side, fixed and stained with
DiffQuik (Dade AG, Düdingen, Switzerland). Cells were
counted in three fields per well at 800× magnification. All
assays were performed in triplicate. In blocking experi-
ments, cell suspensions were preincubated before chemo-
taxis assay for 30 min at 4°C with anti-human CXCR3
mAb at a concentration of 20 µg/ml.
Chemotactic activity of the fluid component of BAL and 
macrophage supernatants
The CXCR3(-) and CXCR3(+) cell lines were also used to
evaluate both the chemotactic activities of macrophage
supernatants and the fluid component of BAL samples.
Supernatants from cell cultures and the fluid components
of BAL were obtained as reported above and used undi-
luted; different concentrations of CXCL10 were utilized as
a positive control. Chemotactic assays were performed as
reported above. In blocking experiments, anti-CXCL10
was added to the cell supernatants before chemotaxis
assay at a concentration of 20 µg/ml.
Statistical analysis
Data were analysed with the assistance of the Statistical
Analysis System. Data are expressed as mean ± SD. Mean
values were compared using the ANOVA test. A P value
<0.05 was considered as significant.
Results
Immunohistochemical analysis of CXCR3 expression in 
lung biopsies
In all cases typical pathological examination showed fea-
tures with poorly formed non-necrotizing granulomas
and widespread thickening of the alveolar walls by a dif-
fuse lymphocytic infiltrate. Pleural lymphoid aggregates
were seen in a few cases and pleural lymphoid aggregates
were seen in a few samples.
Diffuse interstitial lymphocytic infiltrates were character-
ized by an accumulation of T cells and a few B-lym-
phocytes. Sub-pleural and peri-bronchiolar nodules
consisted mostly of T lymphocytes mainly represented by
CD8 cytotoxic T lymphocytes which strongly stained for
CXCR3 in all cases (Figure 1A and 1B). Marked CXCR3
immunostaining was also seen in peribronchial lym-
phocytic infiltrate and in the interstitial non-necrotising
granuloma (Figure 2A and 2B) Both interstitial and intra-
alveolar macrophages (CD 68 positive) showed weak or
negative CXCR3 staining and multinucleated giant cells
always stained negatively (Fig. 2C inset). Endothelial and
epithelial cells close to more intense lymphocytic infil-
trate were sometimes positively marked.
Confocal microscopy analysis of lung biopsies confirmed
that lymphocyte infiltrates were formed by T cells coex-
pressing CXCR3 (Figure 3 panels A, B and C).
Morphological and phenotypical features of cells obtained 
from the BAL
Morphological and phenotypical features of cells
obtained from the BAL of 12 patients with HP and 5 con-
trols are reported in Table 1. All HP subjects showed a
high intensity lymphocytic alveolitis sustained by CD8(+)
Tc1 cells (Table 1 and Figure 4A and 4B). These cells were
CXCR3(+) and bore IFN-γ  but not IL-4 receptor (Figure
4C). Furthermore, pulmonary T cells expressed activatory
molecules such as CD103 and IL-12β 2 receptor (Figure
4C). The percentage and absolute number of BAL
CXCR3(+) was significantly higher in HP patients with
respect to control subjects (Table 2).Respiratory Research 2005, 6:20 http://respiratory-research.com/content/6/1/20
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CXCR3 mediates pulmonary T cell chemotaxis
To define the biological activities of CXCR3, highly puri-
fied T cells obtained from the BALs of patients with HP
were assessed for their migratory capabilities in response
to different concentrations of CXCL10. The evaluation of
the migratory potential of T lymphocytes obtained from
the BAL of the controls was prevented by the low number
of cells recovered. For this reason, the 300-19 T-cell lines
expressing high levels of CXCR3 or not expressing CXCR3
were used as positive and negative controls respectively
for the in vitro chemotaxis assay (Figure 5, panel B and C
respectively).
As shown in panel A of Figure 4, the migratory capability
of T lymphocytes of patients with HP is regulated by
CXCR3. In fact, CXCR3+ lung T cells exhibited a strong,
definite migration in response to CXCL10. To further ver-
ify the functional role of the CXCL10 receptor, CXCR3+
pulmonary T cells were preincubated with anti-CXCR3
neutralizing antibody: the blocking of the receptor deter-
mined a marked inhibition of CXCL10-induced chemo-
taxis (panel A). These data suggest that pulmonary T
lymphocytes that sustain T-cell alveolitis in patients with
HP express a functional CXCR3 receptor and actively
migrate in response to CXCR3 ligands.
Lung macrophages express CXCR3 ligands and release 
ligands showing chemotactic activity on CXCR3(+) cells
In order to analyse whether CXCL10 is expressed in vivo by
lung cells of patients with hypersensitivity pneumonitis,
BAL cells were stained with a anti-CXCL10 antibody as
described above. Flow cytrometric analysis (Figure 6, pan-
els A and B) revealed that AMs of patients with HP express
CXCL10; macrophages retrieved from control subjects
lacked the CXCR3 ligand (panel C).
Measurement of mRNA levels of the CXCR3 ligands dem-
onstrated that unstimulated alveolar macrophages iso-
lated from the BAL of HP subjects expressed increased
mRNA levels of CXCL9 and CXCL10 with respect to mac-
rophages obtained from control subjects (Table 2 and fig-
ure 7). Spearman Rank correlation coefficients between
BAL T CD8(+)/CXCR3(+) T cell number and levels of
CXCR3 ligands were also calculated. Interestingly, a posi-
tive correlation was demonstrated between mRNA levels
Immunohistochemistry for CD8 and CXCR3 in lung biopsy from HP patient Figure 1
Immunohistochemistry for CD8 and CXCR3 in lung biopsy from HP patient. Most lymphocytes positive for CD8 (panel a) and 
CXCR3 (panel b) were clearly visible in a subpleural focus. Original Magnification × 25.
A BRespiratory Research 2005, 6:20 http://respiratory-research.com/content/6/1/20
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of CXCL10 and CXCL9 and the absolute numbers of lung
CD8(+)/CXCR3(+) T cells (r 0.815, p < 0.001 and r 0.825,
p < 0.001, respectively).
Cell-free supernatants were obtained from 24-hour cul-
tured AMs in the presence of IFN-γ  and tested for their
ability to induce T-cell migration. Supernatants obtained
from AMs of patients with HP exerted chemotactic activity
on the CXCR3(+) cell line; the CXCR3(-) cell line did not
migrate in the presence of supernatants (data not shown).
The addition of an anti-CXCL10 neutralizing antibody
inhibited chemotactic activities of supernatants. The
inhibitory activity shown by the neutralizing antibody
was not complete, suggesting that other CXCR3 ligands
(CXCL9 and CXCL11) are likely to be present in
supernatants.
CXCR3 ligands may be demonstrated in the fluid 
component of BAL
To assess whether CXCR3 ligands are released in vivo in
the lung microenvironment, the fluid component of BAL
obtained from 10 HP patients was evaluated for chemo-
tactic activity on CXCR3(+) cell lines (Figure 8). Measura-
ble biological activity was demonstrated in 7 out of 10
patients with HP; this migration was partially abrogated
by an anti-CXCL10 neutralizing antibody.
Immunohistochemistry for CXCR3 in lung biopsy from HP patient: positive marked lymphocytes while negative or weak stain- ing macrophages were also seen in peribronchial space (panel A) and in the setting of non-necrotizing interstitial granuloma  (panel B) (original magnification × 50) Figure 2
Immunohistochemistry for CXCR3 in lung biopsy from HP patient: positive marked lymphocytes while negative or weak stain-
ing macrophages were also seen in peribronchial space (panel A) and in the setting of non-necrotizing interstitial granuloma 
(panel B) (original magnification × 50). Note negative or weak staining of macrophages and giant cells forming the central core 
of the granuloma (inset panel C, original magnification × 100).
A B
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Discussion
We have herein shown that CXCR3 expression represents
a crucial mechanism which is involved in the recruitment
of activated Tc1 cells in the pulmonary microenvironment
of patients with HP. The continuous recruitment of
CXCR3(+) T cells might play a role not only in the
pathogenesis of T-cell alveolitis but also in favouring gran-
uloma formation since T cells surrounding the macro-
phagic core of the HP granuloma expressed this
chemokine receptor. This mechanism is likely to be
shared by various ILDs since we and others have previ-
ously demonstrated the presence of a significant infiltrate
of CXCR3(+) Th1 cells in other ILDs characterized by T
cell alveolitis and granuloma formation, such as sarcoido-
sis and tuberculosis [13,14].
Our data provide definitive confirmation of the recent
findings obtained in an animal model of IFN-γ -knockout
(GKO) mice exposed to the particulate antigen Saccha-
ropolyspora rectivirgula (SR) (i.e., the etiologic agent
involved in the immunopathogenesis of HP reaction in
the majority of our patients) [11]. While WT mice show
the production of IP-10/CXCL10, Mig/CXCL9, and I-TAC/
CXCL11 during the development of the classic HP reac-
tion, GKO mice have reduced or no levels of IP-10/
CXCL10, Mig/CXCL9 and I-TAC/CXCL11 in the lungs and
reduced T-cell alveolitis in response to SR exposure. The
present study suggests the role of CXCL10/CXCR3 and
CXCL9/CXCR3 interactions in driving local CD8 immune
responses to SR (Figure 9). A logical question is whether
our data may have therapeutic implications. Because of
the role of CXCR3 expression in the migration of T cells,
strategies to block CXCL10 could in theory be proposed to
prevent the development of HP reactions, particularly in
subjects continuously exposed to inhaled antigens and
thus at risk for the development of lung fibrosis. Further
Immunofluorescence confocal laser scanning microscopy analysis shows the presence of CXCR3 (panel B, red) on CD3+ T  cells (panel A, green) Figure 3
Immunofluorescence confocal laser scanning microscopy analysis shows the presence of CXCR3 (panel B, red) on CD3+ T 
cells (panel A, green). Panel C shows the overlay image of A and B in yellow (original magnification × 1000).
Table 1: Broncholaveolar findings in patients with hypersensitivity pneumonitis and controls
Study population Cell Recovery Lymphocytes CD4 T cells CD8 T cells
cells × 103/ml % % cells × 103/ml % cells × 103/ml
HP (n. 12) 351.9* ± 62.3 44.4** ± 8.1 25.6** ± 5.3 38.6*** ± 9.3 53.7** ± 6.3 83.4*** ± 8.5
Controls (n. 5) 138.6 ± 12.7 8.2 ± 2.2 48.3 ± 3.2 5.4 ± 0.9 23.7 ± 2.2 2.5 ± 0.3
Significance as follows: *p < 0.05; **p < 0.01; ***p < 0.001
A BCRespiratory Research 2005, 6:20 http://respiratory-research.com/content/6/1/20
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data are required to evaluate the in vivo role of IP-10/
CXL10 in preventing or favouring pulmonary fibrosis in
HP before proposing this strategy.
The relationship between CXCL10 release and the local
production of other chemokines involved in HP immune
response is another important aspect that deserves further
The flow cytometry profile of BAL T cells recovered from 2 representative patients with hypersensitivity pneumonitis and a  control subject Figure 4
The flow cytometry profile of BAL T cells recovered from 2 representative patients with hypersensitivity pneumonitis and a 
control subject. BAL T cells were gated as shown in panel A. In patients with hypersensitivity pneumonitis the majority of lym-
phocytes were CD8(+) T cells (panel B). Panel C shows that BAL T cells from patients with hypersensitivity pneumonitis are 
CD45RO(+) T cells which express CXCR3, IFN-γ  but not IL-4, or other activation markers including CD103 and IL12Rβ 2.
Table 2: Expression of CXCR3 by CD8+ T cells and expression of IP-10/CXCL10 and Mig/CXCL9 mRNAs by alveolar macrophages 
from patients with hypersensitivity pneumonitis and controls*
Study population CXCR3+/CD8+ T cells IP-10/CXCL10 Mig/CXCL9
% cells × 103/ml mRNA levels* mRNA levels
HP (n. 6) 51.7** ± 5.9 80.1*** ± 7.7 2.55** ± 0.14 2.25** ± 0.25
Controls (n. 4) 23.7 ± 2.2 2.5 ± 0.3 0.70 ± 0.05 0.48 ± 0.06
* Band intensity calculated as follows: mm × mm × pixel Significance as follows: **p < 0.01; ***p < 0.001Respiratory Research 2005, 6:20 http://respiratory-research.com/content/6/1/20
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investigation. In a murine model it has recently been
shown that monocyte chemotactic protein-1 (MCP-1/
CCL2) is increased in the BAL of mice challenged with SR
[15]. Furthermore, Pardo et al. [16] have recently exam-
ined the expression of dendritic cell (DC)-derived CC
chemokine 1 (CK1)/CCL18 in the lungs of patients with
HP. CCL18 expression is significantly increased in lungs
affected by HP, with higher levels in the subacute rather
than in the chronic phase of the disease. Macrophages,
dendritic cells, and alveolar epithelial cells are the main
sources of CCL18 whose expression is induced by various
profibrogenic cytokines including IL-4, IL-10, and IL-13.
Interestingly, a direct correlation between the levels of tis-
sue CCL18 and the number of lymphocytes has been
demonstrated in the bronchoalveolar lavage fluids.
Thus, our findings and the data of Pardo et al. [16] suggest
that chemokines ordinarily induced by profibrogenic
cytokines (CCL18) and chemokines induced by antifi-
brotic agents (IFN-γ  and CXCL10) can be demonstrated in
the lung of HP patients with T cell alveolitis. Whether the
presence of the two chemokines is concomitant and there
are common molecular mechanisms involved in the CC
and CXC chemokine release is unknown. Given the heter-
ogeneous pattern of pulmonary infiltrate during different
phases of the disease, a full understanding of the
Chemotactic activity of CXCL10 on BAL CD8(+)/CXCR3(+)T cells highly purified from 2 representative patients with hyper- sensitivity pneumonitis Figure 5
Chemotactic activity of CXCL10 on BAL CD8(+)/CXCR3(+)T cells highly purified from 2 representative patients with hyper-
sensitivity pneumonitis. The assays were performed using a modified Boyden chamber in triplicate and data are given as mean 
± SD. CXL10 shows significant chemotactic activity on BAL T cells (panels A) and the CXCR3(+) T-cell clone (panel B) but not 
on CXCR3(-) T-cell clone.
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Flow cytometric analysis of CXCL10 expression by AMs infiltrating the lung of patients with hypersensitivity pneumonitis Figure 6
Flow cytometric analysis of CXCL10 expression by AMs infiltrating the lung of patients with hypersensitivity pneumonitis. Pan-
els A-C shows the flow cytometry profile of AMs recovered from the BAL of 2 representative patients and a control subject. 
AMs from patients with hypersensitivity pneumonitis (panels A and B) but not control subject (panel C) express CXCL10.
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IP-10/CXCL10 and Mig/CXCL9 mRNA levels expressed by AMs recovered from the BAL of 2 representative patients and 2  control subject Figure 7
IP-10/CXCL10 and Mig/CXCL9 mRNA levels expressed by AMs recovered from the BAL of 2 representative patients and 2 
control subject. AMs from patients with hypersensitivity pneumonitis express higher amounts of IP-10/CXCL10 and Mig/
CXCL9 mRNA levels than control AMs.Respiratory Research 2005, 6:20 http://respiratory-research.com/content/6/1/20
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interdependence of the local hyperproduction of chem-
oattractant molecules may help to clarify the pathogenesis
of HP. In this context, it is also mandatory to investigate
the production of CC chemokines in relationship with
CXCL10 release in individuals with acute, subacute and
chronic HP. For instance, it is known that the combina-
tion of RANTES/CCL5 and CXCL10 but not other chem-
okines (MIP-1α /CCL3, MIP-1β /CCL4, Mig/CXCL9, and
ITAC/CXCL11) markedly increases T-cell recruitment
[17]. Since there are data indicating that circulating, anti-
gen-reactive, memory T cells, generated by previous sensi-
tization to organic antigens, migrate into lung
parenchyma in response to chemokines such as RANTES
[18], it is possible that the interplay of CXCL10 with CCL5
may serve to finely tune inflammatory responses in vivo in
HP lungs.
Conclusion
Our findings clearly indicate the effects of CXCR3/
CXCL10 interactions on hypersensitivity reaction to SR
antigens. Considering the importance of CD8 T cells in
mediating granuloma formation and lung damage, fur-
ther studies are needed in animal models to explore the
therapeutic potential of CXCR3 antagonists with the ulti-
mate goal of offering new clues for immune intervention
in subjects continuously exposed to inhaled antigens and
thus at risk of developing HP-related lung fibrosis.
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The fluid components of the BAL obtained from 4 patients with hypersensitivity patients exert chemotactic activity on the  CXCR3(+) 300-19 T-cell line, indicating the presence of CXCR3 ligand(s) Figure 8
The fluid components of the BAL obtained from 4 patients with hypersensitivity patients exert chemotactic activity on the 
CXCR3(+) 300-19 T-cell line, indicating the presence of CXCR3 ligand(s). The migration was partially abrogated by an anti-
CXCL10 neutralizing antibody (white bars). The assays were performed in triplicate, and data are given as mean ± SD.
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Putative scheme of the effect of the CXCR3/CXL10 interactions in the lung of hypersensitivity patients Figure 9
Putative scheme of the effect of the CXCR3/CXL10 interactions in the lung of hypersensitivity patients. As a consequence of 
the antigenic stimulation APC release IFN-γ . This cytokine stimulates AM to release CXCL10, a chemokine which favours the 
recruitments of activated CD8(+) /CXCR3(+) Tc1 lymphocytes. These cells, which release IFN-γ , in turn contribute to main-
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